Treatment of chronic tension-type headache with botulinum toxin: A double-blind, placebo-controlled clinical trial

Cephalalgia

Volumn 24, Issue 8, 2004, Pages 675-680

  Padberg, M ^a   De Bruijn, S F T M ^a   De Haan, R J ^b   Tavy, D L J ^a  

^a LEYENBURG HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Botulinum toxin; Chronic tension type headache

Indexed keywords

ANALGESIC AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMATOMA; HUMAN; INJECTION PAIN; INJECTION SITE; MALE; MUSCLE WEAKNESS; NAUSEA; PAIN; PAIN ASSESSMENT; PARESTHESIA; SIDE EFFECT; TENSION HEADACHE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PAIN MEASUREMENT; TENSION-TYPE HEADACHE; TREATMENT OUTCOME;

EID: 4043180524     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00738.x     Document Type: Article

References (30)

1. Rasmussen BK, Jensen R, Olesen J. A Population-Based Analysis of the Diagnostic Criteria of the International Headache Society. Cephalalgia 1991; 11:129-34.
2. Goadsby PJ, Boes C. Chronic Daily Headache. J Neurol Neurosurg Psychiatry 2002; 72 Suppl. 2:ii2-ii5.
3. Langemark M, Olesen J. Pericranial Tenderness in Tension Headache. A blind, controlled study. Cephalalgia 1987; 7:249-55.
4. Sakai F, Ebihara S, Akiyama M, Horikawa M. Pericranial Muscle Hardness in Tension-Type Headache. A non-invasive measurement methodand its clinical application. Brain 1995; 118:523-31.
5. Lipchik GL, Holroyd KA, Talbot F, Greer M. Pericranial Muscle Tenderness and Exteroceptive Suppression of Temporalis Muscle Activity. A blind study of chronic tension-type headache. Headache 1997; 37:368-76.
6. Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Muscle Hardness in Patients With Chronic Tension-Type Headache: Relation to Actual Headache State. Pain 1999; 79:201-5.
7. Jensen R, Bendtsen L, Olesen J. Muscular Factors Are of Importance in Tension-Type Headache. Headache 1998; 38:10-7.
8. Bendtsen L. Central Sensitization in Tension-Type Headache - Possible Pathophysiological Mechanisms. Cephalalgia 2000; 20:486-508.
9. Jensen R, Olesen J. Tension-Type Headache. an Update on Mechanisms and Treatment. Curr Opin Neurol 2000; 13:285-9.
10. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson W. Management of Chronic Tension-Type Headache With Tricyclic Antidepressant Medication, Stress Management Therapy, and Their Combination. A randomized controlled trial. J Am Med Assoc 2001; 285:2208-15.
11. Relja M. Treatment of Tension-Type Headache by Local Injection of Botulinum Toxin. Eur J Neurol 1997; 4 Suppl 2:S71-S73.
12. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of Tension-Type Headache With Botulinum Toxin. A pilot study. Eur J Med Res 1999; 4:183-6.
13. Relja M. Treatment of Tension-Type Headache With Botulinum Toxin: 1-Year Follow-Up. Cephalalgia 2000; 20:336.
14. Brans JW, Lindeboom R, Snoek JW, Zwarts MJ, van Weerden TW, Brunt ER, et al. Botulinum Toxin Versus Trihexyphenidyl in Cervical Dystonia: a Prospective, Randomized, Double-Blind Controlled Trial. Neurology 1996; 46:1066-72.
15. Gobel H, Heinze A, Heinze-Kuhn K, Jost WH. Evidence-Based Medicine. Botulinum Toxin A in Migraine and Tension-Type Headache. J Neurol 2001; 248 Suppl 1:34-8. 34-8.
16. Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of Headache With Botulinum Toxin A - a Review According to Evidence-Based Medicine Criteria. Cephalalgia 2002; 22:699-710.
17. Headache Classification Committee of the International Headache Society. Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain. Cephalalgia 1988; 8 Suppl 7:1-96.
18. Schoenen J. Guidelines for Trials of Drug Treatments in Tension-Type Headache. International Headache Society Committee on Clinical Trials, 1st edn. Cephalalgia 1995; 15:165-79.
19. Smuts JA, Baker MK, Smuts HM, Stassen JMR, Rossouw E, Barnard PWA. Prophylactic treatment chronic tension-type headache using bot toxin type A. Eur J Neurol 1999; 6 Suppl 4:S99-S102.
20. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 2000; 40:300-5.
21. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of Botulinum Toxin A Injections in the Treatment of Chronic Tension-Type Headache: a Double-Blind, Placebo-Controlled Trial. Headache 2001; 41:658-64.
22. Dodick DW. Botulinum Neurotoxin for the Treatment of Migraine and Other Primary Headache Disorders: From Bench to Bedside. Headache 2003; 43 Suppl 1:S25-S33.
23. Bendtsen L, Jensen R, Jensen NK, Olesen J. Pressure-Controlled Palpation. a New Technique Which Increases the Reliability of Manual Palpation. Cephalalgia 1995; 15:205-10.
24. Schoenen J. Wolff Award 1992. Exteroceptive Suppression of Temporalis Muscle Activity in Patients With Chronic Headache and in Normal Volunteers: Methodology, Clinical and Pathophysiological Relevance. Headache 1993; 33:3-17.
25. Zwart JA, Sand T. Exteroceptive Suppression of Temporalis Muscle Activity. A Blind Study of Tension-Type Headache, Migraine and Cervicogenic Headache Headache 1995; 35:338-43.
26. Bendtsen L, Jensen R, Brennum J, Arendt-Neilsen L, Olesen J. Exteroceptive Suppression of Temporal Muscle Activity Is Normal in Chronic Tension-Type Headache and Not Related to Actual Headache State. Cephalalgia 1996; 16:251-6.
27. Lipchik GL, Holroyd KA, O'Donnell FJ, Cordingley GE, Waller S, Labus J, et al. Exteroceptive Suppression Periods and Pericranial Muscle Tenderness in Chronic Tension-Type Headache: effects of psychopathology, chronicity and disability Cephalalgia 2000; 20:638-46.
28. Goadsby PJ. Chronic Tension-Type Headache: Where Are We? Brain 1999; 122:1611-2.
29. Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of Inhibition of Nitric Oxide Synthase on Chronic Tension-Type Headache: a Randomised Crossover Trial. Lancet 1999; 353:287-9.
30. Evans RW, Blumenfeld A. Botulinum Toxin Injections for Headache. Headache 2003, 1991; 43:682-5.